Modern Imaging in Prostate Cancer: Do We Treat Patients, or Their Scans?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 35094898.
- Also identified by DOI 10.1016/j.eururo.2022.01.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
New imaging techniques are more sensitive in prostate cancer and reveal sites of disease that may never have been seen with conventional imaging, resulting in stage migration and potentially a change in the clinical management. Until long-term data provide a better understanding of the natural history of the disease defined by more sensitive imaging, patients and clinicians should recognise the considerable uncertainty about whether these improve outcomes. It is hoped that the next iteration of the TNM classification will recognise the problem in some way.
Medical subject headings
- Prostatic Neoplasms